Current Options in the Management of Colorectal Cancer in Developing Countries: Central America Experience
- PDF / 255,239 Bytes
- 6 Pages / 595.276 x 790.866 pts Page_size
- 48 Downloads / 141 Views
SURGERY AND SURGICAL INNOVATIONS IN COLORECTAL CANCER (S HUERTA, SECTION EDITOR)
Current Options in the Management of Colorectal Cancer in Developing Countries: Central America Experience Anny Ochoa-Hernandez 1 & Karen Giron 2 & Jennie Meier 3 & Ana Paulina Charchalac 4 Published online: 11 May 2020 # Springer Science+Business Media, LLC, part of Springer Nature 2020
Abstract Purpose of Review Evaluate the current options in the management of colorectal cancer (CRC) in developing countries. We emphasize the experience in Central America, highlighting the disparities that persist in these countries as compared with developed countries; these are pronounced in many aspects of the health-care system, including lack of health investment, education, and cancer research in the setting of a global increase in malignant diseases. Recent Findings Our analysis demonstrates a multifactorial problem with the absence of government initiatives. There is also lack of interest in the medical community in providing screening for potential curable diseases. Currently, colonoscopy is a screening test widely underutilized in industrialized countries. In developing countries, this is much more pronounced. Summary Central American countries suffer also from lack of current available data to provide an accurate assessment of the status of colorectal cancer. The current report demonstrates the most available evidence in the screening, diagnosis, and treatment of colorectal cancer, with a focus at a county hospital in Guatemala. Keywords Colorectal cancer . Developing countries . Management . Experience Central America
Introduction Colon cancer is a common cancer diagnosis and a major cause of cancer mortality, representing 9.2% of cancer deaths, with an estimated 18.1 million new cases in 2018 worldwide [1]. The mortality in 2014 was 4.3 per 100,000 patients in individuals from 20 to 54 years and is expected to increase by 1.0% per year. Given this pattern, there should be more efficient This article is part of the Topical Collection on Surgery and Surgical Innovations in Colorectal Cancer * Anny Ochoa-Hernandez [email protected] 1
Department of General Surgery, Hospital de San Benito, Peten, San Benito, Guatemala
2
Department of Surgical Oncology, National cáncer institute “Dr. Bernard S. Valley” (INCAN), Guatemala City, Guatemala
3
Department of Surgery, University of Texas Southwestern of Medical Center, Texas, USA
4
Department of Surgery, Hospital de San Benito, Peten, San Benito, Guatemala
screening strategies for early detection, with the ability to provide more accurate treatment strategies [2, 3]. However, even in developed countries, screening strategies for colorectal cancer are widely underutilized [4–6]. The incidence and mortality for colon cancer, as with other malignancies, vary across countries and is partially dependent on the human developing index (HDI). In low- and middleincome countries, there is not an established pattern of reporting cancer cases to cancer registries. There is clear underreporting of malign
Data Loading...
